CHEWTADZY Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chewtadzy, and what generic alternatives are available?
Chewtadzy is a drug marketed by B Better and is included in one NDA.
The generic ingredient in CHEWTADZY is tadalafil. There are twenty-five drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the tadalafil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chewtadzy
A generic version of CHEWTADZY was approved as tadalafil by TEVA PHARMS USA on May 22nd, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHEWTADZY?
- What are the global sales for CHEWTADZY?
- What is Average Wholesale Price for CHEWTADZY?
Summary for CHEWTADZY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | CHEWTADZY at DailyMed |
US Patents and Regulatory Information for CHEWTADZY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Better | CHEWTADZY | tadalafil | TABLET, CHEWABLE;ORAL | 218527-001 | Jun 28, 2024 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Better | CHEWTADZY | tadalafil | TABLET, CHEWABLE;ORAL | 218527-002 | Jun 28, 2024 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Better | CHEWTADZY | tadalafil | TABLET, CHEWABLE;ORAL | 218527-003 | Jun 28, 2024 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
